Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

V. Domenyuk, X. Liu, D. Magee,Z. Gatalica,A. Stark, P. Kennedy, M. Rosenow,A. Barker,D. Berry,G. Poste, D. Halbert, C. Hart,M. Famulok,G. Mayer,M. Korn, M. Miglarese, D. Spetzler

ANNALS OF ONCOLOGY(2018)

引用 6|浏览33
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要